A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.
NCT00349635 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 148
Last updated 2007-09-03
Summary
To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.
Conditions
Interventions
- DRUG
-
Metformin and Metformin + Fenofibrate
Sponsors & Collaborators
-
Solvay Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Global Clinical Director Solvay · Solvay Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
Countries
- Finland
Study Locations
More Related Trials
-
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
NCT03479892 ·Status: COMPLETED ·Phase: PHASE1
-
Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
NCT03051451 ·Status: SUSPENDED ·Phase: PHASE2
-
A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
NCT05429593 ·Status: COMPLETED ·Phase: PHASE1
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety
NCT00735683 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
NCT00748605 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533481 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
NCT05035095 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions
NCT06867718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cardiovascular System in Obesity: Effect of Treatment
NCT00000506 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity
NCT00134303 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
NCT01987427 ·Status: COMPLETED ·Phase: PHASE4
-
Study Exploring the Supportive Effect of Acarbose in Weight Management
NCT05934110 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients
NCT00391196 ·Status: TERMINATED ·Phase: PHASE3
-
A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
NCT07172867 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
NCT07163650 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese
NCT05677867 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
NCT06478563 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
NCT00494767 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.
NCT02354976 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
NCT00959426 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity
NCT00546455 ·Status: SUSPENDED ·Phase: PHASE2
-
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
NCT00747929 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425 ·Status: COMPLETED ·Phase: PHASE2
-
Obese Patients With Type 2 Diabetes
NCT00029848 ·Status: COMPLETED ·Phase: PHASE3